INS and Alzheimer disease: The disruption of the barrier did not induce any cytotoxic effects or alter the localisation pattern of claudin-1, -4, -7 and occludin, suggesting its therapeutic potential and use in intranasal insulin therapy for neurological disorders such as AD [34, 50].